Profil
Shlomit Dekel is the founder of Fio Corp.
She is currently working as a Director at PsyTech Global.
Aktive Positionen von Shlomit Dekel
| Unternehmen | Position | Beginn |
|---|---|---|
PsyTech Global
 PsyTech Global Packaged SoftwareTechnology Services PsyTech Global is a division of iCAN\: Cannabis that combines a robust psychedelic therapeutic community with integrative mental healthcare delivery and enabling tools for novel modalities of care. The Canadian company is a leader in the development of data-driven tools that allow physicians unprecedented insight into patient well-being and clinical best practices. PsyTech is mainstreaming the adoption of psychedelic-assisted therapies through the promotion and delivery of safe and effective therapy, combating stigma, and accelerating innovation. The company also serves as an events platform and innovation scout for psychedelic medicine. Hayim Raclaw has been the CEO of the company since 2020. | Direktor/Vorstandsmitglied | - |
Fio Corp.
 Fio Corp. Packaged SoftwareTechnology Services Fio Corp. It develops a portable point-of-care device capable of molecular diagnosis of multiple infectious diseases simultaneously from a small biological sample. The company is headquartered in Toronto, ON. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Fio Corp.
Fio Corp. Packaged SoftwareTechnology Services Fio Corp. It develops a portable point-of-care device capable of molecular diagnosis of multiple infectious diseases simultaneously from a small biological sample. The company is headquartered in Toronto, ON. | Technology Services |
PsyTech Global
PsyTech Global Packaged SoftwareTechnology Services PsyTech Global is a division of iCAN\: Cannabis that combines a robust psychedelic therapeutic community with integrative mental healthcare delivery and enabling tools for novel modalities of care. The Canadian company is a leader in the development of data-driven tools that allow physicians unprecedented insight into patient well-being and clinical best practices. PsyTech is mainstreaming the adoption of psychedelic-assisted therapies through the promotion and delivery of safe and effective therapy, combating stigma, and accelerating innovation. The company also serves as an events platform and innovation scout for psychedelic medicine. Hayim Raclaw has been the CEO of the company since 2020. | Technology Services |